You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 20, November 26, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Dr Peppercorn and colleagues, one of the major goals of our study was to determine whether a broad range of causes of critical illness could induce CMV reactivation. Thus, we intentionally included patients from 4 ICUs (cardiac, trauma, burn, and medical) and demonstrated that CMV reactivation occurred in response to each of the insults (myocardial infarction, trauma, burn, or sepsis) associated with their respective ICUs. Despite differences in the incidence, timing, and duration of CMV reactivation by ICU, the finding that such diverse insults could all lead to CMV reactivation is a novel observation.

In the primary analysis that included all ICUs, we did not find an independent association between ICU type and risk of CMV reactivation in multivariable analysis adjusted for age, sex, and race (Table 3). There were significant differences in the primary composite end point (continued hospitalization or death by day 30) . . . [Full Text of this Article]

Ajit P. Limaye, MD
limaye@u.washington.edu
University of Washington
Seattle

Wendy M. Leisenring, ScD; Michael Boeckh, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients
Amanda Peppercorn, Jonathan Serody, and Bruce Cairns
JAMA. 2008;300(20):2367-2368.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.